Published in Haematologica on February 01, 1982
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ (1998) 6.07
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Travel and risk of venous thrombosis. Lancet (2000) 5.23
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med (1996) 4.10
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med (2003) 3.94
Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis. Nat New Biol (1973) 2.43
Increased factor IX levels in puerperium during administration of diethylstilboestrol. Br Med J (1968) 2.29
Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med (1998) 2.03
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology (1995) 1.57
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med (1996) 1.45
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1994) 1.40
STRAIN ELECTROMETRY AND CORROSION I. GENERAL CONSIDERATIONS ON INTERFACIAL ELECTRICAL TRANSIENTS. Proc Natl Acad Sci U S A (1957) 1.39
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica (1999) 1.38
Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med (1974) 1.36
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Flow-field-flow fractionation: a versatile new separation method. Science (1976) 1.26
Two-dimensional separations: concept and promise. Anal Chem (1984) 1.24
Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24
The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21
Rapid diffusion coefficient measurements using analytical SPLITT fractionation: application to proteins. Anal Biochem (1993) 1.20
Hepatitis C virus and Sjögren's syndrome. Lancet (1992) 1.19
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Serum albumin in Hodgkin's disease. Cancer (1985) 1.17
Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15
The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency. Br J Haematol (1975) 1.15
Electrical field-flow fractionation of proteins. Science (1972) 1.13
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica (2000) 1.08
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
Properties of an asymmetrical flow field-flow fractionation channel having one permeable wall. Anal Chem (1987) 1.07
The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer (1990) 1.07
Long-term interferon-beta treatment for multiple sclerosis. Neurol Sci (2003) 1.06
Ovarian cancer and venous thromboembolic risk. Gynecol Oncol (2005) 1.05
Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture. Thromb Res (1983) 1.02
Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart (2002) 1.02
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. J Thromb Haemost (2007) 1.01
Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol (1977) 1.00
Primary splenic lymphoma: does it exist? Haematologica (1994) 1.00
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Br J Haematol (1984) 1.00
Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes. Haemostasis (1974) 1.00
Rapid protein separation and diffusion coefficient measurement by frit inlet flow field-flow fractionation. Protein Sci (1993) 0.99
Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg (2000) 0.98
Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat (2004) 0.96
Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95
Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer (1983) 0.95
Fractionating power in programmed field-flow fractionation: exponential sedimentation field decay. Anal Chem (1987) 0.95
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95
Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology (1994) 0.94
Value of factor VIII related antigen as a means of demonstrating extramedullary megakaryopoiesis. J Clin Pathol (1984) 0.94
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Separation of human and animal cells by steric field-flow fractionation. Cell Biophys (1984) 0.94
Can causes of false-normal D-dimer test [SimpliRED] results be identified? Thromb Res (2003) 0.94
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost (2005) 0.94
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res (1988) 0.93
Hodgkin's disease prognosis: a directly predictive equation. Lancet (1988) 0.93
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
Hydrodynamic relaxation in flow field-flow fractionation using both split and frit inlets. Anal Chem (1991) 0.93
Flow field-flow fractionation: new method for separating, purifying, and characterizing the diffusivity of viruses. J Virol (1977) 0.93
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J Clin Oncol (1994) 0.93
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol (2004) 0.93
Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood (1997) 0.92
Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax (2002) 0.92
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther (1998) 0.92
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol (1989) 0.91
Factor VIII (antihaemophilic factor) in tissues detected by antibody neutralization. Br J Haematol (1972) 0.90
Preparation and use of a new artificial system for factor XI assay. Med Lab Technol (1971) 0.90
Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse. Thromb Res (2005) 0.90
A prognostic index for multiple myeloma. Br J Cancer (1996) 0.90
Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis. J Med Virol (1992) 0.89
Is autoimmune chronic active hepatitis a HCV-related disease? J Hepatol (1991) 0.89
The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica (1999) 0.89
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. Haematologica (1975) 0.89
Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J Thromb Haemost (2009) 0.89
Epsilon-aminocaproic acid for synovectomy in haemophilic patients. Acta Haematol (1972) 0.88
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepat (2001) 0.88
Tissue localization and synthesis of factor-VIII-related antigen in the human foetus. Br J Haematol (1974) 0.88
Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes. Cancer (1983) 0.88
Statistical method for estimation of number of components from single complex chromatograms: theory, computer-based testing, and analysis of errors. Anal Chem (1985) 0.88
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia (1993) 0.87
Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in a hematological/oncological outpatient section. Haematologica (1989) 0.87
Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura. Clin Exp Rheumatol (1988) 0.87
The immunological localization of factor V in human tissue. Br J Haematol (1975) 0.87
Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk. Am J Epidemiol (1991) 0.87
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica (1997) 0.87